Science Explorer Back to mapMap
Discussion
Researcher · Fate Therapeutics (United States) · United States

Daniel D. Shoemaker

Daniel D. Shoemaker publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, CRISPR and Genetic Engineering and Pluripotent Stem Cells Research.

OpenAlex
World rank
#731,384
of 7,710,434 ranked researchers
Rank in United States
#246,287
of 1,627,098
Works
56
Citations
18k
Citations per work
317.6
h-index
21
i10-index 23Top 30% in Molecular Biology
Daniel D. Shoemaker

What does Daniel D. Shoemaker research?

Daniel D. Shoemaker's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (20%), Immunology and Microbiology (10%).

Life Sciences: 36 works · 64.7% of their workBiochemistry, Genetics and Molecular Biology: 29 works · 52.3% of their workMolecular Biology: 27 works · 48.4% of their workGenetics: 2 works · 3.9% of their workImmunology and Microbiology: 5 works · 9.8% of their workImmunology: 5 works · 9.8% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 2.6% of their workPharmaceutical Science: 1 works · 2.6% of their workHealth Sciences: 11 works · 20.3% of their workMedicine: 11 works · 20.3% of their workOncology: 7 works · 11.8% of their workHematology: 5 works · 8.5% of their workEverything else: 8 works · 15.0% of their workTHEIR WORKDaniel D.Shoemaker56works
Life Sciences65%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2952.3%
    2. Immunology and Microbiology59.8%
    3. Pharmacology, Toxicology and Pharmaceutics12.6%
    1. Medicine1120.3%
  3. Everything else815.0%
  1. 1Molecular Biology48% of their works
  2. 2Oncology12% of their works
  3. 3Immunology10% of their works
  4. 4Hematology8% of their works
  5. 5Genetics4% of their works
  6. 6Pharmaceutical Science3% of their works

Research topics

Which keywords describe Daniel D. Shoemaker's research?

The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Gene Expression, Genome Engineering, RNA-Guided, Bone Marrow Niche, Hematopoietic Stem Cells and Induced Pluripotent Stem Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. CAR T Cells151 topic
  2. Chimeric Antigen Receptor151 topic
  3. Gene Expression152 topics
  4. Genome Engineering111 topic
  5. RNA-Guided111 topic
  6. Bone Marrow Niche101 topic
  7. Hematopoietic Stem Cells101 topic
  8. Induced Pluripotent Stem Cells101 topic
  9. Pluripotent Stem Cells101 topic
  10. Data Analysis81 topic
  11. Microarray81 topic
  12. NK Cell Recognition81 topic
  13. Natural Killer Cells81 topic
  14. Genomics71 topic
  15. Ribosome71 topic
  16. Translation71 topic
  17. Yeast71 topic

Where does Daniel D. Shoemaker work?

Daniel D. Shoemaker's main affiliation in the publication record is Fate Therapeutics (United States), United States.

How many publications and citations does Daniel D. Shoemaker have?

OpenAlex counts 56 works and 17,787 citations for Daniel D. Shoemaker, an h-index of 21, ranking #731,384 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Daniel D. Shoemaker. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.